아발로 테라퓨틱스 (AVTX)

Avalo Therapeutics Inc (AVTX) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	63.30% 0.236	0.643	0.475	0.896	14.95
Cost Of Revenue	65.11% 0.247	0.708	0.551	0.62	0.528
Gross Profit	83.08% -0.011	-0.065	-0.076	0.276	14.42
Operating Expenses	47.23% 3.739	7.085	8.716	9.131	10.33
Benefits Costs and Expenses	38.20% 5.456	8.829	10.42	6.51	11.75
Costs And Expenses	48.85% 3.986	7.793	9.267	9.751	10.85
Operating Income/Loss	47.55% -3.75	-7.15	-8.792	-8.855	4.095
Nonoperating Income/Loss	41.89% -1.47	-1.036	-1.155	-0.949	-0.898
Income/Loss From Continuing Operations Before Tax	36.23% -5.22	-8.186	-9.947	-5.614	3.197
Income Tax Expense/Benefit, Deferred	14.29% 0.008	0.007	0.008	0.008	0.005
Income Tax Expense/Benefit	14.29% 0.008	0.007	0.008	0.008	-
Income/Loss From Continuing Operations After Tax	36.19% -5.228	-8.193	-9.955	-9.812	3.192
Net Income/Loss	36.19% -5.228	-8.193	-9.955	-9.812	3.192
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	234.70% 46.76	13.97	11.72	-	-
Diluted Average Shares	234.70% 46.76	13.97	11.72	-	-
Basic Earnings Per Share	81.36% -0.11	-0.59	-0.85	-	-
Diluted Earnings Per Share	81.36% -0.11	-0.59	-0.85	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-